Literature DB >> 17849060

JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation.

Gema Plumé1, Amparo Vayá, Fernando Ferrando, Yolanda Mira, Francisco Orbis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17849060

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  3 in total

1.  Etiology and portal vein thrombosis in Budd-Chiari syndrome.

Authors:  Oguz Uskudar; Meral Akdogan; Nurgul Sasmaz; Sevinc Yilmaz; Muharrem Tola; Burhan Sahin
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

2.  Budd-Chiari Syndrome in a Patient with JAK-2 V617F and Factor V G1691A Mutations.

Authors:  J S Velarde-Félix; J Sanchez-Zazueta; F P Gonzalez-Ibarra; J A González-Valdez; B Salcido-Gómez; E Gallardo-Angulo; J Murillo-Llanes
Journal:  West Indian Med J       Date:  2014-06-10       Impact factor: 0.171

3.  The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.

Authors:  Ipek Yonal; Binnur Pinarbası; Fehmi Hindilerden; Veysel Sabri Hancer; Meliha Nalcaci; Sabahattin Kaymakoglu; Reyhan Diz-Kucukkaya
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.